Related Experiment Video

Updated: May 2, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.5K

Hyperuricemia and cardiovascular risk

Davide Grassi1, Giovambattista Desideri, Anna Vittoria Di Giacomantonio

  • 1Department of Life, Health and Environmental Sciences, University of L'Aquila, Viale S Salvatore, Delta 6 Medicina, 67100, Coppito L'Aquila, Italy, davide.grassi@cc.univaq.it.

High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|February 21, 2014
PubMed

Insights

High uric acid levels (hyperuricemia) and gout are rising globally. These conditions are independent risk factors for hypertension, kidney disease, and cardiovascular disease, increasing overall health burdens.

Area of Science:

  • Cardiology
  • Nephrology
  • Rheumatology

Background:

  • Gout and hyperuricemia prevalence is increasing worldwide.
  • Gout is a chronic disease with significant individual and social burden.
  • Hyperuricemia is increasingly recognized as a risk factor for chronic diseases.

Purpose of the Study:

  • To review evidence on the relationship between hyperuricemia and comorbid conditions.
  • To highlight hyperuricemia as a risk factor for cardiovascular disease.
  • To discuss the management of gout as a chronic disease state.

Main Methods:

  • Review of multiple epidemiologic studies.
  • Analysis of evidence linking hyperuricemia to cardiovascular risk.
  • Synthesis of data on comorbidities associated with hyperuricemia.

Main Results:

  • Hyperuricemia and gout are independent risk factors for hypertension, renal disease, and cardiovascular disease.
  • Epidemiologic studies confirm an association between hyperuricemia and cardiometabolic disease.
  • Hyperuricemia contributes to the development of comorbidities that increase cardiovascular risk.

Conclusions:

  • Hyperuricemia is a significant contributor to cardiovascular risk.
  • Effective long-term management of gout and hyperuricemia is crucial.
  • Understanding the link between hyperuricemia and comorbidities is essential for patient care.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
6.7K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
757
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
762